Positive Patient Stories™

Investor Overview

Webcast ImageWebcast - Replay
Paratek Pharmaceuticals to Present at LEERINK Partners 7th Annual Global Healthcare Conference
02/14/18 at 2:30 p.m. ET
Paratek Pharmaceuticals to Present at LEERINK Partners 7th Annual Global Healthcare Conference
Wednesday, February 14, 2018 2:30 p.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast - Live
Q4 2017 Paratek Pharmaceuticals Inc Earnings Conference Call
03/01/18 at 8:30 a.m. ET
Q4 2017 Paratek Pharmaceuticals Inc Earnings Conference Call
Thursday, March 1, 2018 8:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar

Corporate Profile

Paratek is developing and commercializing innovative antibacterial therapeutics based upon tetracycline chemistry. Paratek has used its expertise in microbial biology and tetracycline chemistry to create chemically diverse and biologically distinct small molecules derived from the tetracycline class of molecules. Paratek’s two lead antibacterial product candidates are omadacycline and sarecycline. Omadacycline entered Phase 3 clinical development in June 2015. Sarecycline entered Phase 3 clinical development in December 2014.

Stock Information

PRTK (Common Stock)
ExchangeNASDAQ (US Dollar)
Price$13.35
Change (%) Stock is Up 0.15 (1.14%)
Volume294,682
Data as of 02/23/18 4:00 p.m. ET

Latest News

02/15/18
Paratek Pharmaceuticals to Report Fourth Quarter and Full Year 2017 Financial Results on March 1, 2018
02/05/18
Paratek Completes Submission of New Drug Applications to U.S. Food and Drug Administration for Oral and Intravenous Omadacycline for Pneumonia and Skin Infections
02/01/18
Paratek Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
01/31/18
Paratek Pharmaceuticals to Present at LEERINK Partners 7th Annual Global Healthcare Conference
See More >>
Data provided by Nasdaq. Minimum 15 minutes delayed.

Talk with the Paratek Team

Send us an inquiry by submitting a form directly on the site or give us a call.